-+ 0.00%
-+ 0.00%
-+ 0.00%

AARDVARK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN AUSTRALIA IN HERO PHASE 3 TRIAL FOR PRADER-WILLI SYNDROME

Reuters·12/10/2025 21:05:00

Please log in to view news